| Market Cap | 318 | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -11.71M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
| Sales | -4.14M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -99.00% |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | -100.00% |
| Recommedations | - | Quick Ratio | - | Shares Outstanding | 370.66M | 52W Low Chg | - |
| Insider Own | - | ROA | -7.77% | Shares Float | - | Beta | -8.21 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00010 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 14,424 | Target Price | - |
| Oper. Margin | -35.61% | Earnings Date | - | Volume | 121,100 | Change | 0.00% |
Terme Bancorp, Inc. is a holding company, which through its subsidiaries, provides financial services which includes mortgage brokerage, and global electronic money services to consumers by offering general-purpose reloadable (GPR) cards. It also invests in various consumer-oriented medical initiatives, including medical devices, health maintenance, and health enhancement products. The company was formerly known as Umbrella Bancorp, Inc. and changed its name to Terme Bancorp, Inc. in January 2007. Terme Bancorp, Inc. was incorporated in 1987 and is based in Chicago, Illinois.
